Erschienen in:
01.03.2008 | Hepatobiliary-Pancreas
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions
verfasst von:
Renate Hammerstingl, Alexander Huppertz, Josy Breuer, Thomas Balzer, Anthony Blakeborough, Rick Carter, Lluis Castells Fusté, Gertraud Heinz-Peer, Werner Judmaier, Michael Laniado, Riccardo M. Manfredi, Didier G. Mathieu, Dieter Müller, Koenraad Mortelè, Peter Reimer, Maximilian F. Reiser, Philip J. Robinson, Kohkan Shamsi, Michael Strotzer, Matthias Taupitz, Bernd Tombach, Gianluca Valeri, Bernhard E. van Beers, Thomas J. Vogl, For the European EOB-study group
Erschienen in:
European Radiology
|
Ausgabe 3/2008
Einloggen, um Zugang zu erhalten
Abstract
A multicenter study has been employed to evaluate the diagnostic efficacy of magnetic resonance imaging (MRI) using the new liver-specific contrast agent gadoxetic acid (Gd-EOB-DTPA, Primovist), as opposed to contrast-enhanced biphasic spiral computed tomography (CT), in the diagnosis of focal liver lesions, compared with a standard of reference (SOR). One hundred and sixty-nine patients with hepatic lesions eligible for surgery underwent Gd-EOB-DTPA-enhanced MRI as well as CT within 6 weeks. Pathologic evaluation of the liver specimen combined with intraoperative ultrasound established the SOR. Data sets were evaluated on-site (14 investigators) and off-site (three independent blinded readers). Gd-EOB-DTPA was well tolerated. Three hundred and two lesions were detected in 131 patients valid for analysis by SOR. The frequency of correctly detected lesions was significantly higher on Gd-EOB-DTPA-enhanced MRI compared with CT in the clinical evaluation [10.44%; 95% confidence interval (CI): 4.88, 16.0]. In the blinded reading there was a trend towards Gd-EOB-DTPA-enhanced MRI, not reaching statistical significance (2.14%; 95% CI: −4.32, 8.6). However, the highest rate of correctly detected lesions with a diameter below 1 cm was achieved by Gd-EOB-DTPA-enhanced MRI. Differential diagnosis was superior for Gd-EOB-DTPA-enhanced MRI (82.1%) versus CT (71.0%). A change in surgical therapy was documented in 19 of 131 patients (14.5%) post Gd-EOB-DTPA-enhanced MRI. Gd-EOB-DTPA-enhanced MRI was superior in the diagnosis and therapeutic management of focal liver lesions compared with CT.